Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
136
days
Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis
Authors
Joseph Yang; Bonnie H. Bui; Tim Bancroft; Andrea Steffens; Rebecca Fee; Bijan J. BorahShow moreShow less
Affiliations
1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Optum, Inc., Eden Prairie, USA; 3. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, USAShow moreShow less
143
days
Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review
Authors
Anna L. Heilig; Wilbert B. van den Hout; M. Elske van den Akker-van MarleShow moreShow less
Affiliations
1. Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The NetherlandsShow moreShow less
61
days
Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients
Authors
Vivian Reckers-Droog; Steef Redeker; Jan Busschbach; Sylvia Vijgen; Angèl Link; Lonneke TimmersShow moreShow less
Affiliations
1. Erasmus School of Health Policy and Management, Section Health Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands; 2. National Health Care Institute, Diemen, The Netherlands; 3. Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus University Medical Center, Rotterdam, The NetherlandsShow moreShow less
262
days
Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology
Authors
Brian Reddy; Claire Telford; Apoorva Ambavane; Sugam Mahajan; J. Jaime CaroShow moreShow less
Affiliations
1. Pfizer Healthcare Ireland, Dublin, Ireland; 2. Pfizer Inc., New York City, USA; 3. ThermoFisher, Dubai, UAE; 4. ThermoFisher, Gurgaon, India; 5. ThermoFisher, Waltham, USA; 6. McGill University, Montreal, CanadaShow moreShow less
187
days
Application of a Prevalence-Adjusted Cost-Effectiveness Threshold Framework for Pulmonary Arterial Hypertension
Authors
Adnan Alsumali; Vasco M. Pontinha; Benjamin G. Cohen; Meghan Levy; William V. PadulaShow moreShow less
Affiliations
1. Merck & Co., Inc., Rahway, USA; 2. Department of Pharmacotherapy and Outcomes Research, VCU School of Pharmacy, Virginia Commonwealth University, Richmond, USA; 3. Stage Analytics, Suwanee, USA; 4. Department of Pharmaceutical and Health Economics, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, USA; 5. The Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, USAShow moreShow less
60
days
Developing French Population Tariffs for the ICECAP-A Using Best–Worst Scaling
Authors
Zexuan Wang; Jonathan Sicsic; Pauline ChauvinShow moreShow less
Affiliations
1. Liraes and Chaire AgingUP!, Universite Paris Cité, Paris, France; 2. Liraes, Universite Paris Cité, Paris, FranceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days